Cleaning up the oceansFrench green chemistry pioneer, Carbios SA (Clermont-Ferrand) announced in March that it has secured equity financing of €2.5m from Kepler Cheuvreux through the acquisition of 380,000 shares over 24 … more ➔
Acquisition: Thermo enters CMO worldLab equipment giant Thermo Fisher Scientific Inc. is growing even bigger. more ➔
Orphan drugs: Treating a raritySince US senators in February conveyed the impression that drug developers might have misused market monopolies related to orphan drugs (ODs) to overprice their compounds, the status has come under closer … more ➔
Allergies: Public Enemy Number OneThe concept has been around for more than a century, but recent advances in the field are causing numerous experts to say its widely underused. The goal of allergen immunotherapy (AIT) is to induce … more ➔
Update of bioeconomy strategy unsureUncertainty regarding the amount of future funding and political support from the European Commission for the bioeconomy is set to hamper investments into the switch from oil-based industry production … more ➔
Serialisation: Time is running outDrug makers have only until two years from now to make their drugs and packaging counterfeit-resistant. By 9 February, 2019, every prescription drug pack must carry a 2D data matrix code that can be … more ➔
Biomanufacturing: The smell of successUntil recently, aroma compounds were either sourced directly from plants or made from petrochemicals with the help of chemical synthesis processes. Now a handful of biotechnological production approaches … more ➔
Preventing congestion in acute heart failu...German Adrenomed AG has decided to start clinical Phase II tests of the very first personalised treatment for the six million patients with acute congestive heart failure. Large trials suggest that the … more ➔
Longevity: Healthy ageingItalian, Swedish, and German researchers have started recruitment for a systematic investigation into the factors affecting longevity. more ➔
Blood cancer: Boosting chemotherapy effect...German and Swedish researchers have presented a strategy to predict and improve chemotherapy outcomes in patients with acute myelogenous leukaemia (AML). Currently, the five-year overall survival rate … more ➔
